Issues relating to medical device cybersecurity and artificial intelligence.
Issues related to the sterilization of medical devices.
Duration: February 1, 2019
to
present
General Issues: Telecommunications , Environmental/Superfund , Health Issues , Medicare/Medicaid , Budget/Appropriations , Trade (Domestic & Foreign) , Consumer Issues/Safety/Protection , Taxation/Internal Revenue Code
Spending: about $600,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Commerce - Dept of (DOC)
Related Foreign Entities:
Medronic PLC (Dublin, IRL); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
H.W. Menn III Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
H.W. Menn II Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on April 22.
Original Filing: 301570625.xml
Lobbying Issues
Issues relating to medical device cybersecurity and artificial intelligence.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the sterilization of medical devices.
4th Quarter, 2023
In Q4, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Jan. 22.
Original Filing: 301535287.xml
Lobbying Issues
Issues relating to medical device cybersecurity.
Lobbying Issues
Issues related to the sterilization of medical devices.
Lobbying Issues
Issues relating to medical device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage and payment for breakthrough medical devices.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Oct. 13, 2023.
Original Filing: 301500582.xml
Lobbying Issues
Monitor issues relating to medical device cybersecurity.
Lobbying Issues
Monitor issues related to the sterilization of medical devices.
Lobbying Issues
Monitor device shortage reporting issues related to the reauthorization of Pandemic and All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare coverage and payment for breakthrough medical devices.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on July 20, 2023.
Original Filing: 301492320.xml
Lobbying Issues
Monitor issues relating to medical device cybersecurity.
Lobbying Issues
Monitor issues related to the sterilization of medical devices.
Lobbying Issues
Monitor device shortage reporting issues related to the reauthorization of Pandemic and All Hazards Preparedness Act.
1st Quarter, 2023
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on April 17, 2023.
Original Filing: 301453772.xml
Lobbying Issues
Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor issues relating to medical device cybersecurity.
Lobbying Issues
Monitor issues related to the sterilization of medical devices.
4th Quarter, 2022
In Q4, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Jan. 19, 2023.
Original Filing: 301432333.xml
Lobbying Issues
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to S. 4348 (FDASLA Act of 2022), H.R. 7667 (Food and Drug Amendments of 2022), S.3799 (PREVENT Pandemics Act), Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor issues relating to medical device cybersecurity.
Lobbying Issues
Monitor Environmental, Social and Governance (ESG) issues relating to the health sector.
3rd Quarter, 2022
In Q3, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405678.xml
Lobbying Issues
Inflation Reduction Act (H.R. 5376).
Lobbying Issues
Monitoring issues relating to medical device cybersecurity.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667-The Food and Drug Amendments of 2022; Issues relating to the Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor Environmental, Social and Governance (ESG) issues relating to the health sector.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIPS Act of 2022 (P.L. 117-167)
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2022
In Q2, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on July 20, 2022.
Original Filing: 301390691.xml
Lobbying Issues
Issues related to stroke care and transportation protocols for stroke victims.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitoring issues relating to medical device cybersecurity. H.R.7084 and S.3983-PATC Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667-The Food and Drug Amendments of 2022; Issues relating to the Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on April 14, 2022.
Original Filing: 301356456.xml
Lobbying Issues
Monitoring issues related to global supply chains.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to stroke care and transportation protocols for stroke victims.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitoring issues relating to medical device cybersecurity.
Lobbying Issues
H.R. 7084-Protecting and Transforming Cyber Health Care Act of 2022; S. 3799-PREVENT Pandemics Act relating to reporting provisions in Sec. 515 and 516.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Jan. 22, 2022.
Original Filing: 301339448.xml
Lobbying Issues
Issues related to global supply chains.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Medicare policies relating to continuous glucose monitors and closed loop systems; Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of Reasonable and Necessary Final Rule [86 Fed. Reg. 26849 (May 18, 2021)].
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301306342.xml
Lobbying Issues
Issues related to global supply chains.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Medicare policies relating to continuous glucose monitors and closed loop systems; Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of Reasonable and Necessary Final Rule [86 Fed. Reg. 26849 (May 18, 2021)].
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on July 19, 2021.
Original Filing: 301281458.xml
Lobbying Issues
Issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to global supply chains.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues relating to Medicare policies on continuous glucose monitoring and closed loop systems.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY2022 Transportation, Housing and Urban Development, and Related Agencies appropriations relating to the NHTSA transportation destination protocols for stroke patients.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on April 21, 2021.
Original Filing: 301268569.xml
Lobbying Issues
Issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to global supply chains.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues relating to Medicare policies on continuous glucose monitoring and closed loop systems.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY2022 Transportation, Housing and Urban Development, and Related Agencies appropriations relating to the NHTSA transportation destination protocols for stroke patients.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Jan. 18, 2021.
Original Filing: 301232937.xml
Lobbying Issues
Issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to onshoring medical manufacturing.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to Medicare policies regarding continuous glucose monitoring and closed loop systems.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Oct. 16, 2020.
Original Filing: 301211316.xml
Lobbying Issues
Issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws. Issues relating to sterilization of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7616-FY2021 Transportation, Housing and Urban Development, and Related Agencies appropriations relating to the NHTSA transportation destination protocols for stroke patients.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues relating to onshoring medical manufacturing.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to Medicare policies on continuous glucose monitoring and closed loop systems.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301191856.xml
Lobbying Issues
Issues relating to global medical device supply; Issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws. Issues relating to sterilization of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.7616-FY2021 Transportation, Housing and Urban Development,and Related Agencies appropriations relating to the NHTSA transportation destination protocols for stroke patients.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1842-The Protecting Personal Health Data Act; S. 2962-The Consumer Online Privacy Rights Act; Issues related to data privacy and data security.
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2020
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on April 16, 2020.
Original Filing: 301168952.xml
Lobbying Issues
The Patient Affordability Value and Efficiency Act; issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws. Issues relating to sterilization of medical devices; H.R. 748-Coronavirus Aid, Relief, and Economic Security Act relating to device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating the NHTSA transportation destination protocols for stroke patients.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1842-The Protecting Personal Health Data Act; S. 2962-The Consumer Online Privacy Rights Act; issues related to data privacy and data security.
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2019
In Q4, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301109171.xml
Lobbying Issues
H.R. 2207 & S.692-Protect Medical Innovation Act relating to repeal of the medical device tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
The Patient Affordability Value and Efficiency Act; issues relating to healthcare value-based arrangements and modernization of fraud and abuse laws. Issues relating to sterilization of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1865-Further Consolidated Appropriations Act 2020 relating to Sec. 501 repeal of medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $20,000. The report was filed on Oct. 17, 2019.
Original Filing: 301067718.xml
Lobbying Issues
H.R. 2207-Protect Medical Innovation Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
The Patient Affordability Value and Efficiency Act; issues relating to anti-kickback and physician self-referral prohibitions relating to healthcare value-based arrangements.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $20,000. The report was filed on July 17, 2019.
Original Filing: 301048218.xml
Lobbying Issues
H.R. 2207-Protect Medical Innovation Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
The Patient Affordability Value and Efficiency Act; issues relating to anti-kickback and physician self-referral prohibitions relating to healthcare value-based arrangements;issues relating to non-pharmacological pain treatment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, GOVERNMENT COUNSEL, LLC lobbied for Medtronic Inc. , earning $20,000. The report was filed on April 17, 2019.
Original Filing: 301027398.xml
Lobbying Issues
The Patient Affordability Value and Efficiency Act; issues relating to anti-kickback and physician self-referral prohibitions relating to healthcare value-based arrangements.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2207-Protect Medical Innovation Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to non-pharmacological pain treatment
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...